U.S. Motion Preservation Device Market to Exhibit Continuing Growth Beyond 2015, States iData Research
13 Sep 2012 • by Natalie Aster
The market for traditional spinal implants has faced numerous challenges including an uncertain U.S. economy, adverse clinical data, poor insurance reimbursement rates, as well as the limiting effect minimally invasive devices have had on traditional methodologies. One such segment that is drawing attention away from the traditional market is minimally invasive sacroiliac joint fusion, according to the new in-demand market research report “U.S. Market for Minimally Invasive Spinal Devices” developed by iData Research.
“Sacroiliac (SI) joint dysfunction has been found to be responsible for nearly one quarter of lower back pain cases, a significant discovery considering the traditionally low diagnosis rate,” says Dr. Kamran Zamanina, CEO of iData Research. To remedy the problems caused by SI joints, companies have manufactured implants to treat the disease in a minimally invasive fashion. The first of such technologies to enter the U.S. market was SI-BONE’s iFuse Implant System®, followed by Zyga Technology’s SImmetry™ sacroiliac joint fusion system. The combined sales of Zyga Technology and SI-BONE led to nearly 150% market growth in 2011. With new products expected from companies such as Signus Medical and Globus Medical, this market is expected to exhibit accelerated growth rates in 2012 and beyond.
The motion preservation device market’s focus on minimally invasive techniques will be coupled with a continuation of being the largest contributor to the rising spinal implant market. “In 2011 this market experienced growth of nearly 20% in the United States, which was highly attributed to the increasing artificial disc segment,” Dr. Zamanian noted. Only three competitors participate in the artificial disc market: Synthes, Medtronic and DePuy. Lumbar discs have been commercially available in the U.S. for longer, but are still not nationally covered by as many insurance payers as cervical artificial discs. In the midst of this growing industry, Medtronic has maintained its position as the industry leader through innovation and acquisitions.
Aside from artificial discs, the motion preservation device market is further augmented by the markets for annular closure devices and interspinous process spacers. Both of these markets are monopolized by a single competitor: Anulex in the annular closure market and Medtronic in the interspinous process spacer market. Anulex manufactures the Xclose™ and Inclose™ systems designed for soft tissue repair, while the interspinous process spacer market relies on Medtronic’s X-STOP® IPD® system. There is an anticipated surge of new products from companies such as Eden Spine, Paradigm Spine and the future U.S. launch of Intrinsic Therapeutics’ device, the Barricaid®.
Future segments in the motion preservation device market include nucleus replacement devices and facet arthroplasty systems. Many nucleus replacement devices that were previously under development have been terminated, but a number of promising products are still scheduled for market release in the near future. Facet arthroplasty systems, which are designed to be used conjunctively lumbar artificial discs, are expected to be a promising market due to their indications and facilitative properties. Taking emerging technologies into consideration, the motion preservation device market is forecasted to maintain double-digit growth rates, exceeding a market size of $1 billion by 2018.
Other prominent leaders in the U.S. spinal implant markets include DePuy, NuVasive, Synthes, Stryker and Zimmer.
Along with Medtronic, these five companies encompass the vast majority of the market. However, a number of other competitors such as Alphatec Spine, K2M, Lanx, Globus and Titan Spine are also developing reputations of their own in niche markets. Emerging markets, namely nucleus replacement devices and facet arthroplasty, will also bring about their own assortment of competitors.
iData’s 2012 report “U.S. Market for Minimally Invasive Spinal Devices” provides a comprehensive analysis of their respective markets in the United States.
U.S. Market for Minimally Invasive Spinal Devices
Published: July, 2012
Price: US$ 7.495,00
More information can be found in the report “U.S. Market for Minimally Invasive Spinal Devices” by iData Research.
To order the report or ask for sample pages contact [email protected]